Cochrane Abstracts
Mycobacterium vaccae immunotherapy for treating tuberculosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Mycobacterium Vaccae Immunotherapy for Treating Tuberculosis." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432773/all/Mycobacterium_vaccae_immunotherapy_for_treating_tuberculosis.
Mycobacterium vaccae immunotherapy for treating tuberculosis. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432773/all/Mycobacterium_vaccae_immunotherapy_for_treating_tuberculosis. Accessed April 27, 2025.
Mycobacterium vaccae immunotherapy for treating tuberculosis. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432773/all/Mycobacterium_vaccae_immunotherapy_for_treating_tuberculosis
Mycobacterium Vaccae Immunotherapy for Treating Tuberculosis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 April 27]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432773/all/Mycobacterium_vaccae_immunotherapy_for_treating_tuberculosis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Mycobacterium vaccae immunotherapy for treating tuberculosis
ID - 432773
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432773/all/Mycobacterium_vaccae_immunotherapy_for_treating_tuberculosis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
